Desloratadine

• Evaluation of Allergen Specific Vaccination of Dog Allergic Patients in Swedish Practice Pending
  2024-517649-15-00 Phase IV 1 country Karolinska Institutet
• A clinical trial to evaluate the efficacy and safety of a mixture of allergenic extracts of D. pteronyssinus and D. farinae, in patients suf… Pending
  2025-521230-29-00 Phase III 1 country LETI Pharma S.L.U.
• Phase III clinical trial of ABCB5+ MSCs for the treatment of EB Recruiting
  2022-500266-10-00 Phase III 12 countries Rheacell GmbH & Co. KG
• A prospective, randomized, double-blind, placebo-controlled, multicentre, dose-finding clinical trial with polymerised mannan-conjugated all… Recruiting
  2025-524580-21-00 Phase II/III 1 country Inmunotek S.L.
• A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN) ( PREVAIL ) Recruiting
  2024-519345-30-00 Phase III 11 countries Biogen Idec Research Limited
• Long-term clinical trial of PQ Grass in paediatric subjects with seasonal allergic rhinitis and/or rhinoconjunctivitis induced by grass poll… Recruiting
  2023-508520-36-00 Phase III 7 countries Allergy Therapeutics (UK) Limited
• A clinical trial to compare three oral treatments and a placebo in preventing skin reactions caused by histamine in healthy volunteers Ended
  2024-516569-35-00 Phase IV 1 country A. Menarini Industrie Farmaceutiche Riunite S.r.l.; Faes Farma S.A.
• A prospective, randomized, double-blind placebo-controlled multicentre trial with mannan-conjugated birch pollen allergoids administered sub… Ended
  2024-515717-17-00 Phase III 1 country Inmunotek S.L.
• Phase 1/2a Open-Label, Dose-Escalation, Multicenter, First in-Human, Consecutive-Cohort, Clinical Trial of BI 1910, a Monoclonal Antibody to… Ended
  2022-503066-74-00 Phase I (FiH) 5 countries Bioinvent International AB

Showing 1–9 of 9 trials